Articles From: Celadon Group Reports Third Fiscal Quarter Financial Results and Declares Dividend to Dyax Corp. Announces First Quarter 2013 Financial Results

Celadon Group Inc. (NYSE: CGI) today reported its financial and operating results for the three months ended March 31, 2013, the third fiscal quarter of the Company’s fiscal year ending June 30, 2013.

- Funds from Operations (FFO) Up 20% - Net Operating Income (NOI) Excluding Lease Cancellation Income Up 5% - Mall Tenant Sales Per Square Foot Up 5.6% - Net Income, Average Rent Per Square Foot, Occupancy, and Leased Space Up BLOOMFIELD HILLS, Mich.

Independent Bank Corp., (NASDAQ: INDB) , parent of Rockland Trust Company, today announced net income for the first quarter of 2013 was $12.3 million, or $0.54 on a diluted earnings per share basis.

ATHENS, Greece , April 25, 2013 /PRNewswire/ -- Paragon Shipping Inc. (NASDAQ: PRGN) ("Paragon Shipping", or the "Company"), a global shipping transportation company specializing in drybulk cargoes, announced today its results for the three months ended March 31, 2013 .

HUNTINGTON BEACH, Calif., April 25, 2013 (GLOBE NEWSWIRE) -- BJ's Restaurants, Inc. (Nasdaq:BJRI) today reported financial results for its first quarter of fiscal 2013 that ended on Tuesday, April 2, 2013.

WARREN, N.J. , April 25, 2013 /PRNewswire/ -- The Chubb Corporation [NYSE: CB] today reported that net income in the first quarter of 2013 was $656 million , compared to $506 million in the first quarter of 2012.

(Adds statement from AMC) By Ben Fritz Walt Disney Co.

Fluor Corporation (NYSE: FLR) , in a consortium with GE Hitachi Nuclear Energy (GEH), has been selected by Dominion Virginia Power (NYSE: D) to provide project development services for its proposed 1,470-megawatt nuclear unit at its North Anna Power Station in Louisa County, Va.

Sonic Foundry, Inc. (NASDAQ: SOFO) , the trusted market leader for video management and academic, enterprise and event webcasting , today announced financial results for its fiscal 2013 second quarter ended March 31, 2013.

Total Revenue Continues Steady Growth of 10 Percent; Progress on All Aspects of the Business Financial Highlights ($ in millions, except per share data, unaudited)   Q1 2013 Q1 2012 Percent Change Total BioMarin Revenue  $ 127.9  $ 116.6 9.7% Total Net Product Revenue  127.3  116.2 9.6% Naglayzme Net Product Revenue  69.4  68.6 1.2% Aldurazyme BioMarin Net Product Revenue  16.7  12.0 39.2% Kuvan Net Product Revenue  37.6  32.0 17.5% Firdapse Net Product Revenue  3.6  3.6 0.0% GAAP Net Loss  (39.8)  (24.0)   GAAP Net Loss per Share (basic and diluted)  $ (0.31)  $ (0.21)   Non-GAAP Adjusted EBITDA Loss

Outerwall Reflects Future Vision and Limitless Possibilities BELLEVUE, Wash.

COLUMBIA, Md.

RECORD THIRD QUARTER REVENUE, NET INCOME AND EPS NEW STOCK BUYBACK PLAN APPROVED COLUMBIA, Md.

KILGORE, Texas, April 25, 2013 (GLOBE NEWSWIRE) -- Martin Midstream Partners L.P. (Nasdaq:MMLP) announced today it has declared a quarterly cash distribution of $0.775 per unit for the quarter ended March 31, 2013 and plans to publicly release its financial results and file its quarterly report on Form 10-Q for the quarter ended March 31, 2013 after the market closes on Monday, May 6, 2013.

CINCINNATI , April 25, 2013 /PRNewswire/ --  Cincinnati Financial Corporation (Nasdaq: CINF) today reported: First-quarter 2013 net income of $154 million , or 94 cents per share, compared with $86 million , or 53 cents per share, in the first quarter of 2012.

Wynn Resorts, Limited (Nasdaq: WYNN) today reported financial results for the first quarter ended March 31, 2013.

AUSTIN, Texas , April 25, 2013 /PRNewswire/ -- The National Instruments (Nasdaq: NATI) Board of Directors announced a quarterly dividend of $0.14 per share on the company's common stock.

http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010851&ProfileId=051205&sourceType=1 NORTHBROOK, IL --

http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010485&ProfileId=051205&sourceType=1 PETALUMA, CA --

http://media.marketwire.com/attachments/201103/22940_CalAmp_Logo_MW_735148.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010949&ProfileId=051205&sourceType=1 OXNARD, CA --

http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010972&ProfileId=051205&sourceType=1 NEW YORK, NY --

Derma Sciences, Inc. (Nasdaq: DSCI) , a medical device and pharmaceutical company focused on advanced wound care, announces that patient screening has begun in the second of two Phase 3 clinical trials with the investigational topical drug candidate DSC127 for the treatment of diabetic foot ulcers.

NEW YORK , April 25, 2013 /PRNewswire/ -- - RAISES 2013 GUIDANCE - - EBITDA GUIDANCE INCREASED FROM $132-135 MILLION TO $142-146 MILLION , IMPLYING YEAR OVER YEAR GROWTH OF +20% TO +23%   FIRST QUARTER HIGHLIGHTS:    Revenue increased from $235.2 million to $267.0 million , an increase of 13.6% Organic revenue increased 10.1% EBITDA increased from $8.4 million to $30.4 million , an increase of  262.7% EBITDA margin increased 780 basis points from 3.6% to 11.4%, an increase of 217% Free Cash Flow increased $22.0 million from an outflow of ($7.1) million to positive $14.9 million Debt refinancing materially reduces cost of capital and cash interest expense moving forward MDC Partners Inc. ("MDC Partners" or the "Company") today announced financial results for the three months ended March 31 , 2013.

NEW YORK , April 25, 2013 /PRNewswire/ -- MDC Partners Inc. ("MDC Partners" or the "Company") today announced that its Board of Directors has declared a cash dividend of $0.28 per share on all of its outstanding Class A shares and Class B shares.

OncoGenex to Webcast Discussion of Clinical Development Program and First Quarter 2013 Financial Results on May 2, 2013 Canada NewsWire To access the webcast, log on to the Investor Relations page of the OncoGenex website at www.oncogenex.com .

BOTHELL, WA and VANCOUVER, BC , April 25, 2013 /PRNewswire/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's first quarter 2013 financial results will be released on Thursday, May 2, 2013 , and that the Company will host a conference call and live webcast at 4:30 p.m. ET that afternoon.

Urologix ® , Inc. (Nasdaq: ULGX) will host a conference call to present fiscal year 2013 third quarter results on Wednesday, May 1, 2013 at 4:00 p.m. CT, following the Company’s post-market press release on the same day.

Q1 2013 Highlights - Record first quarter revenue of $286 million, up 10 percent year-over-year - Record orders for a first quarter in LabVIEW, PXI, CompactRIO and NI CompactDAQ products - GAAP gross margin of 75.5 percent and non-GAAP gross margin of 76.6 percent - Fully diluted GAAP EPS of $0.15 and fully diluted non-GAAP EPS of $0.21 AUSTIN, Texas , April 25, 2013 /PRNewswire/ -- National Instruments (Nasdaq: NATI) today announced Q1 revenue of $286 million , a new first quarter record and a 10 percent increase from Q1 2012.

Seventh Consecutive Quarter of Year-Over-Year Growth CHELMSFORD, Mass.

Dyax Corp.